Risk of infections and cardiovascular and venous thromboembolic events associated with JAK inhibitors in rheumatoid arthritis: protocols of two systematic reviews and network meta-analyses

INTRODUCTION: Janus kinases (JAK) inhibitors demonstrated to be effective in the treatment of adult patients with moderate-to-severe active rheumatoid arthritis (RA) but have been associated with serious cardiovascular and serious events. Two systematic reviews and network meta-analyses will be carr...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí: Alves, Carlos, Penedones, Ana, Mendes, Diogo, Batel-Marques, Francisco
Formáid: Online Alt Téacs
Teanga:English
Foilsithe / Cruthaithe: BMJ Publishing Group 2020
Ábhair:
Rheumatology
Rochtain ar líne:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780510/
https://www.ncbi.nlm.nih.gov/pubmed/33384392
http://dx.doi.org/10.1136/bmjopen-2020-041420

Ar líne

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780510/
https://www.ncbi.nlm.nih.gov/pubmed/33384392
http://dx.doi.org/10.1136/bmjopen-2020-041420

Míreanna comhchosúla